The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,788.50
Bid: 1,788.50
Ask: 1,789.00
Change: 32.50 (1.85%)
Spread: 0.50 (0.028%)
Open: 1,743.50
High: 1,792.50
Low: 1,740.50
Prev. Close: 1,756.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BUZZ-U.S. STOCKS ON THE MOVE-Synta Pharma, Lorillard, BioCryst, Insmed

Tue, 31st Mar 2015 12:04

(For faster updates on individual market-movers, Eikon usersplease use search string "STXBZ US"; for the Day Aheadnewsletter, http://link.reuters.com/mex49s; for the Morning NewsCall newsletter, http://link.reuters.com/nex49s)U.S. stock index futures were lower on Tuesday, indicating amodest retreat from the previous session's rally, including thestrongest session for the Dow in more than a month. Dow Jonesindustrial average e-mini futures were down 0.43 percentat 17,784, S&P 500 futures were down 0.49 percent at2,065.25 and Nasdaq 100 futures were down 0.42 percent at4,354.

** SYNTA PHARMACEUTICALS CORP, Monday close$2.33, -18.45 pct premarket

The drug developer said it would commence a public offeringof common shares, but did not say when the offering would becompleted or provide any details on the number of shares orprice.

** REYNOLDS AMERICAN INC, Monday close $69.47, -2.02pct premarket

** LORILLARD INC, Monday close $66.42, -3.49 pctpremarket

The Federal Trade Commission staff is recommending a suit toblock the $27 billion merger of the second- and third-biggestcigarette makers, Reynolds American and Lorillard, the New YorkPost reported, citing a well-placed DC source not working on thecase said. (http://bit.ly/1xuMHLZ)

** INSMED INC, Monday close $21.09, -3.70 pctpremarket

The drug developer said it is offering 10 million shares ofits common stock, and intends to use the proceeds to developrespiratory drugs ARIKAYCE and INS1009.

** TECK RESOURCES LTD, Monday close $15.27, -7.86pct premarket

The Canadian miner and Antofagasta Plc are exploring a merger that would create one of the world'sbiggest copper producers, Bloomberg reported, citing people withknowledge of the matter.

** GLAXOSMITHKLINE PLC, Monday close $47.2, -1.80pct premarket

** JOHNSON & JOHNSON, Monday close $101.55, -0.25pct premarket

GlaxoSmithKline has agreed to settle a lawsuit byJohnson & Johnson accusing it of using false advertising at thestart of the U.S. allergy season to grab market share.

** GROUPON INC, Monday close $7.43, -2.02 pctpremarket

** KKR & CO LP, Monday close $22.77

Private equity firms KKR and Hong Kong-based Anchor Partnersare in talks to buy a majority stake in Groupon's South Koreanunit for around 350 billion won ($316 million), a South Koreannewspaper reported on Tuesday.

($1 = 1,107.3200 won)

** CBRE GROUP INC, Monday close $36.41

** JOHNSON CONTROLS INC, Monday close $49.83, +1.73pct premarket

Johnson Controls, a maker of climate control systems forbuildings, said it would sell its global workplace solutionsbusiness to CBRE for $1.48 billion in cash. CBRE, the world'slargest commercial real estate services firm, said it expectsthe deal to add to adjusted earnings in 2016.

** ENDURANCE SPECIALTY HOLDINGS LTD, Monday close$64.3

** MONTPELIER RE HOLDINGS LTD, Monday close$38.15, +3.54 pct premarket

Property and casualty insurer Endurance Specialty will buyreinsurer Montpelier Re for about $1.83 billion in cash andstock. Montpelier shareholders will get 0.472 Endurance shareand $9.89 in cash for each share held, the companies said onTuesday.

** BIOCRYST PHARMACEUTICALS INC, Monday close$8.57, +5.13 pct premarket

The drug developer said it won a U.S. government contractfor the continued development of its potential treatment forviral diseases, including Ebola. The 18-month contract includesa base value of $12.1 million to support manufacturing, as wellas $22.9 million in additional development options that can beexercised by the government.

** CHARTER COMMUNICATIONS INC, Monday close$183.39, +7.97 pct premarket

The cable television operator has agreed to acquire BrightHouse Networks in a roughly $10 billion deal that could beannounced as soon as Tuesday, according to a source familiarwith the matter. The deal is contingent on Comcast Corp's acquisition of Time Warner Cable Inc beingapproved by U.S. regulators, the source said.

** MOSAIC CO, Monday close $47.36, +0.25 pctpremarket

The U.S. fertilizer company said it would raise its annualdividend by 10 cents to $1.10 per share, effective in May. Themove comes despite recent tax changes by the Canadian provinceof Saskatchewan, where Mosaic mines the crop nutrient potash,which the company said earlier would cost it $80 million to $100million in 2015.

** QUEST DIAGNOSTICS INC, Monday close $77.69

** QUINTILES TRANSNATIONAL HOLDINGS INC, Monday close$68

Medical test maker Quest Diagnostics and contract researchcompany Quintiles Transnational said they were combining theirclinical trial laboratory operations in a joint venture, ofwhich Quintiles will own 60 percent.

** CABLEVISION SYSTEMS CORP, Monday close $18.48

The U.S. cable T.V. operator is planning to make an offerfor the New York Daily News as early as this week, valuing thetroubled tabloid at just $1, according to a person familiar withthe matter.

** INTERNATIONAL BUSINESS MACHINES CORP, Mondayclose $162.67

The company said it would invest $3 billion over the nextfour years in a new 'Internet of Things' unit, aiming to sellits expertise in gathering and making sense of the surge inreal-time data.

** HERBALIFE LTD, Monday close $42.72

Hedge fund mogul William Ackman, who has spent more than twoyears accusing Herbalife of running a pyramid scheme, said onMonday that shutting down the company is "one of the mostimportant things" he can do.

** STARBUCKS CORP, Monday close $95.98

Starbucks and Danone SA will begin selling asmoothie line at more than 4,300 U.S. Starbucks shops as part ofa Greek yogurt partnership that will also include yogurtparfaits and ready-to-eat yogurt to be sold by grocers.

** CITIGROUP INC, Monday close $51.64

The U.S. bank has agreed to sell its credit card unit inJapan to Sumitomo Mitsui Trust Bank, the companies said onTuesday, as Citi slims down globally to bolster itsprofitability.

** CONOCOPHILLIPS, Monday close $64

The American oil company plans to invest about $2.5 billionin Indonesia's upstream oil and gas industry over the next threeor four years, the nation's energy minister said on Tuesday.

** ALIBABA GROUP HOLDING LTD, Monday close $83.9

The online retailer's healthcare subsidiary will tie-up withZhejiang DiAn Diagnostics Co Ltd to help develop anonline hospital platform, the diagnostics firm said in a filinglate on Monday.

** EXXON MOBIL CORP, Monday close $85.63

The oil and gas producer said it started production in thedeepwater Gulf of Mexico at Hadrian South, its deepest subseatie-back. The daily gross production from the project isexpected to reach about 300 mln cubic feet of gas and 3,000barrels of liquids from two wells.

** VAALCO ENERGY INC, Monday close $3.13

The oil and gas producer said it is abandoning its firstwell drilled offshore Angola as it was found to bewater-bearing. (Compiled by Ramkumar Iyer in Bengaluru; Editing by SimonJennings)

More News
5 Mar 2024 11:03

GSK says ViiV's cabotegravir study supports longer HIV dose interval

(Alliance News) - GSK PLC on Tuesday celebrated study results from ViiV Healthcare Ltd, that showed an investigational formulation of cabotegravir can be dosed at four-month intervals.

Read more
5 Mar 2024 07:26

GSK's ViiV upbeat on ultra-long-acting HIV treatment study

(Sharecast News) - GSK announced on Tuesday that its specialist GIV joint venture with Pfizer and Shionogi, ViiV Healthcare, had reported encouraging results from its phase one clinical trial of an investigational formulation of cabotegravir, termed cabotegravir ultra long-acting (CAB-ULA).

Read more
29 Feb 2024 09:44

TOP NEWS: GSK avoids "protracted litigation" with Zantac settlement

(Alliance News) - GSK PLC on Thursday emphasised its commitment to science, as it reached another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
29 Feb 2024 07:22

GSK reaches settlement in another Zantac case

(Sharecast News) - GSK announced a confidential settlement with Boyd/Steenvoord, effectively resolving a case filed in California state court over its discontinued heartburn drug Zantac.

Read more
26 Feb 2024 08:25

GSK gonorrhoea treatment achieves efficacy endpoint in latest trial

(Alliance News) - GSK PLC on Monday announced positive results from the latest trial of its oral gonorrhoea treatment, showing it to be on par with intramuscular therapies.

Read more
26 Feb 2024 07:22

GSK reports positive results from gonorrhoea treatment trial

(Sharecast News) - GSK announced encouraging headline outcomes from its trial of gepotidacin, an oral antibiotic aiming to address uncomplicated urogenital gonorrhoea in adolescents and adults, on Monday.

Read more
21 Feb 2024 09:47

GSK reports encouraging results for ViiV's Cabenuva HIV treatment

(Alliance News) - GSK PLC on Wednesday said that its majority-owned company ViiV Healthcare had received positive interim data from ongoing trials of its injectable HIV treatment.

Read more
21 Feb 2024 07:22

GSK's ViiV sees success in latest HIV treatment trial

(Sharecast News) - GSK's specialist HIV unit ViiV Healthcare, which it owns in partnership with Pfizer and Shionogi, unveiled promising findings from the 'LATITUDE' phase three trial of its long-acting injectable HIV treatment Cabenuva on Wednesday.

Read more
20 Feb 2024 15:10

PRESS: AJ Bell founder to join Applied Nutrition ahead of IPO - Sky

(Alliance News) - Supplements maker Applied Nutrition, plotting a London stock market float, is to add AJ Bell PLC founder Andy Bell as its chair, Sky News reported on Tuesday.

Read more
20 Feb 2024 08:55

IN BRIEF: Diageo welcomes GSK's CFO as non-executive director

Diageo PLC - London-based brewer and distiller sells more than 200 drinks brands, including Guinness stout, Captain Morgan rum and Johnnie Walker whisky - Appoints GSK PLC's chief financial officer and executive director, Julie Brown, as a non-executive director. Says she will succeed Alan Stewart as chair of the audit committee after his retirement following the firm's annual general meeting in September. Chair Javier Ferran says: "Julie brings many years of experience in financial, commercial and strategic roles in international companies operating in highly regulated industries. She is strongly committed to enabling diversity in business and to creating sustainable, long-term value for stakeholders. I look forward to her contribution to Board discussions and to working with her in progressing Diageo's ambition to be one of the most trusted and respected consumer products companies in the world."

Read more
15 Feb 2024 14:44

UK dividends calendar - next 7 days

Friday 16 February 
JPMorgan Asia Growth & Income PLCdividend payment date
JPMorgan Japan Small Cap Growth & Income PLCdividend payment date
Murray International Trust PLCdividend payment date
Premier Miton Group PLCdividend payment date
Schroder Oriental Income Funddividend payment date
Solid State PLCdividend payment date
Monday 19 February 
no events scheduled 
Tuesday 20 February 
Invesco Bond Income Plus Ltd 
Wednesday 21 February 
no events scheduled 
Thursday 22 February 
abrdn Asia Focus PLCex-dividend payment date
Alumasc Group PLCex-dividend payment date
AstraZeneca PLCex-dividend payment date
BlackRock Throgmorton Trust PLCex-dividend payment date
Braemar PLCex-dividend payment date
easyJet PLCex-dividend payment date
Ecofin US Renewables Infrastructure Trust PLCex-dividend payment date
Endeavour Mining PLCex-dividend payment date
FRP Advisory Group PLCex-dividend payment date
Gateley Holdings PLCex-dividend payment date
GSK PLCex-dividend payment date
Hercules Site Services PLCex-dividend payment date
Jersey Electricity PLCex-dividend payment date
Land Securities Group PLCex-dividend payment date
Molten Ventures VCT PLCex-dividend payment date
Northern Bear PLCex-dividend payment date
Redrow PLCex-dividend payment date
Samuel Heath & Sons PLCex-dividend payment date
Titon Holdings PLCex-dividend payment date
Unilever PLCex-dividend payment date
Van Elle Holdings PLCex-dividend payment date
Virgin Money UK PLCex-dividend payment date
Witan Investment Trust PLCex-dividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
15 Feb 2024 11:02

Berenberg hikes target price on GSK

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker GSK from £16.50 to £18.20 on Thursday, stating the group was moving closer to offsetting losses associated with the expiry of its patent on HIV drug dolutegravir.

Read more
15 Feb 2024 09:45

LONDON BROKER RATINGS: Jefferies cuts Kingfisher but Citi raises

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
15 Feb 2024 08:49

GSK completes USD1.4 billion purchase of respiratory firm Aiolos Bio

(Alliance News) - GSK PLC on Thursday said it has completed the acquisition of Aiolos Bio Ltd, expanding its respiratory portfolio with a potential "best-in-class" asthma treatment.

Read more
13 Feb 2024 16:53

LONDON MARKET CLOSE: Stocks in red amid sticky US inflation data

(Alliance News) - Stock prices in London closed in the red on Tuesday, after a key US inflation reading came in hotter-than-expected.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.